SC
LXRX icon

Sessa Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sessa Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5M Buy
18,960,836
+1,047,875
+6% +$2.04M 0.76% 20
2026
Q1 		$27.9M Buy
17,912,961
+14,912,961
+497% +$21.7M 0.51% 25
2025
Q4 		$3.45M Hold
3,000,000
– – 0.06% 29
2025
Q3 		$4.05M Hold
3,000,000
– – 0.1% 27
2025
Q2 		$2.84M Buy
+3,000,000
New +$1.94M 0.08% 25

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sessa Capital's LXRX Position: Q2 2026 in Review

Sessa Capital increased its Lexicon Pharmaceuticals (LXRX) stake by 5.8% in Q2 2026, buying an estimated $2.04M and bringing the position to 18,960,836 shares worth $45.5M. The position accounts for 0.76% of the portfolio, ranked #20.

Sessa Capital first reported a position in LXRX in Q2 2025 and has held it in 5 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Sessa Capital held 18,960,836 shares of Lexicon Pharmaceuticals worth $45.5M as of Q2 2026.
  • Sessa Capital bought 1,047,875 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $2.04M.
  • Lexicon Pharmaceuticals made up 0.76% of Sessa Capital's portfolio in Q2 2026, its #20 holding.
  • Sessa Capital first reported a position in Lexicon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Sessa Capital's 13F filing for Q2 2026, filed 14 Aug 2026.